R & D Platform

R & D Platform

Bioscience Americas ...Solutions for a Healthier World.

Immunology & Inflammation

Our goal is to transform chronic inflammatory diseases, many of which are poorly managed by existing treatments that only provide symptom relief, at best. We seek to address the root cause of this inflammation at a molecular level and develop first-in-class or best-in-class stem cell protocols.  We continue to advance GIOSTAR’s leading science on the pathway, developing tailored therapies targeting specific aspects in key autoimmune diseases such as lupus.

We are also advancing programs targeting inflammation in the lung and kidneys, where environmental or internal “danger signals” in the body trigger inflammatory responses that can lead to chronic kidney disease, chronic obstructive pulmonary disease (COPD). Key to our approach is re-engaging the body’s innate immunity and key pathways of tissue remodeling and fibrosis.

Longer-term, we are increasingly studying the potential to reset immune system homeostasis by targeting immunoregulation.


Neurologic and psychiatric diseases are some of the most devastating disorders of our time, causing significant disability around the world. Our scientists are targeting neurodegenerative and neuropsychiatric diseases through a Precision Medicine approach, rooted in human biology, neuroimaging, novel biomarkers and a deeper understanding of brain circuitry.

Our Neuroscience researchers are exploring the origins of central nervous system (CNS) diseases using genetics, neurophysiology, and functional brain imaging to design next generation therapeutics. Pain encompasses a distinct group of conditions with unique underlying biology, affecting patients in different ways depending on co-morbidities, background genetics and psychology.